July 30 | Standards and precise and infinite care -the sixth Eli Lili China Gastrointestinal Tumor Summit Forum is about to strike!

*For medical professionals for reading reference

The year after five years, as always, speaking academics. On July 30, 2022 (Saturday), the sixth session of the Lili Lili China Gastroenterology Tumor Summit Forum is about to strike. Since the first session of the Summit Forum in 2017, it has been successfully held for five sessions. With high -quality academic content and the style close to clinical practice, it has become an academic ceremony that has attracted much attention in the field of digestive tumors. Here, the medical community invites you to participate in this conference!

The main theme of this year's peak forum is "the forefront of smart gathering, unlimited future", focusing on the four themes of "specifications, precision, infinite, care". Professor Xu Ruihua and Professor Zhang Suzhan, the Second Affiliated Hospital of Zhejiang University Medical College, as the chairman of the conference, gathered well -known experts in the field of digestive tumors in China, and discussed the focus of colorectal cancer in multi -directional and multi -perspectives. Difficulties and hotspots, communication experience, collision thinking, and jointly help the development of Chinese gastrointestinal tumor diagnosis and treatment. At that time, well -known experts in the field of digestive tract gathered offline, the cloud meets, multi -platform broadcasts are broadcast simultaneously, wonderful, not to be missed! Please share the audiovisual academic feast.

In this issue of the medical community, one of the chairman of the conference, Professor Shen Lin from Peking University Cancer Hospital shared new progress and breakthroughs in precision treatment of colorectal cancer, as well as future development direction.

Expert Introduction

Professor Shen Lin

Director of the Department of Internal Medicine of Gastrointestinal and Director of Phase I Clinical Test Ward

He has served as Deputy Dean of Peking University Cancer Hospital and Deputy Director of the Institute of Beijing Cancer Prevention and Control Research

Beijing scholar

Chairman of the China Anti -Cancer Association Cancer Precision Treatment Professional Committee

The first chairman of the China Anti -Cancer Association Oncology Clinical Research Committee

Chairman of the China Clinical Oncology Society Clinical Research Expert Committee

The chairman of the Stomach Cancer Committee of the China Clinical Oncology Society

Deputy Chairman of the Professional Committee of the Chinese Anti -Cancer Association

Chairman of the Rotating Chairman of the Beijing Cancer Prevention and Control Society

Professor Shen Lin: The advancement of genetic testing technology helps to diagnose colorectal cancer diagnosis and treatment. The discovery and exploration of rare targets and new targets, and the application of tiny residual lesions (MRDs) are expected to bring revolutionary progress to the treatment of colorectal cancer.

For more experts to interview wonderful content, please click to read the original text in the lower left corner to see the details

- END -